With the support of philanthropists in Qatar, the Qatar Charity Office opened a project to expand and equip the Khalifa Dialysis Center in the Yemeni governorate of Taiz. The number of beneficiaries of the project, which is the only center in the region, is estimated at 1,000 beneficiaries.

The project aims to improve the health status of kidney failure patients in Taiz Governorate and enhance the ability of the health staff to provide services of appropriate quality and find sustainable solutions to ensure the center continues to provide the necessary health services.

Providing equipment

This intervention includes expanding the building and basic facilities of the Khalifa Dialysis Center, where a building was added that can accommodate 10 dialysis machines with beds for patients and the provision of all facilities and services for them, in addition to building housing for the medical staff and providing all basic medical equipment and means of transportation to the center by providing an ambulance to transport patients and provide insurance, A car to provide the center’s services, a solar energy system, providing medicines, solutions, and medical materials, and support for operational expenses and incentives provided to the staff working in the health center.

Director of the Industrial Experts Department, Abu Bakr Abdul Aziz, decided: “There is considered a useful center for helping patients who previously remained and had not previously returned in the centers of the neighboring governorates or to the capital, Sana’a.”

It is worth noting that Qatar Charity, within the framework of an agreement with OCHA in Yemen, worked last year to support nine health facilities in the districts of Taiz and Ibb, in addition to covering transportation costs for emergency cases and ensuring access to health care services for displaced people. It also implemented in 2023 an emergency health assistance project for patients with low incomes. Limited, as the medical intervention included performing cardiac catheterization operations and correcting congenital heart defects in children, in addition to treating cancer patients.